Abstract
Purpose: In the present study, the potential clinical role of 11C-acetate PET mainly in the differential diagnosis, in the staging and in the follow-up of prostate cancer patients is reported. Methods: Each of the above points has been accurately investigated by studying the specific biochemical and radiobiochemical behaviour of this positron emitter compound. Results and Conclusion: The imaging quality of 11C-acetate PET and its unique mechanisms of cellular uptake, make such radiotracer a powerful tool in evaluating all the steps of the prostatic cancer. © 2007 Springer-Verlag.
Author supplied keywords
Cite
CITATION STYLE
Soloviev, D., Fini, A., Chierichetti, F., Al-Nahhas, A., & Rubello, D. (2008, May). PET imaging with 11C-acetate in prostate cancer: A biochemical, radiochemical and clinical perspective. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-007-0662-4
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.